Dr. Miver Erem Tokuş
NeurosurgeryVerified
- 24+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Brain Surgery
Transnasal resection of tumor
What transnasal resection of tumor involves, how endoscopes access skull base and pituitary tumors through the nasal passages, clinical evidence on resection rates, approximate costs in Turkey compared with the UK, US and Germany, hospital recovery, potential complications such as CSF leaks, and guidance on selecting an experienced skull base neurosurgical team.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Brain Surgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Transnasal Resection of Tumor
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Transnasal resection of tumor: what it is and how endoscopic skull base surgery works
Transnasal resection of tumor—commonly termed endoscopic endonasal skull base surgery or transsphenoidal tumor resection—is a minimally invasive technique used to remove growths at the cranial base. Rather than opening the skull with a craniotomy or making facial incisions, surgeons guide rigid endoscopes and precision instruments through the natural nasal corridors. The surgical path traverses the sphenoid sinus to reach the sella turcica, clivus, and adjacent skull base compartments. It is most frequently performed for pituitary adenomas, craniopharyngiomas, chordomas, Rathke cleft cysts, and selected meningiomas.
Because the skull base sits near the optic chiasm, carotid arteries, and cranial nerves, the procedure requires high anatomical precision. In modern hospitals, the operation is conducted by a co-surgeon team: an ear, nose, and throat (ENT) rhinologist and a skull base neurosurgeon. This dual approach provides clear visualisation while protecting nasal function. For patients seeking cranial care, hospitals offering transnasal resection of tumor in Turkey provide dedicated multidisciplinary pathways alongside other specialised neurosurgery treatments in Turkey.
How does endoscopic transnasal resection access skull base lesions?
Accessing the cranial base through the nostrils follows defined micro-anatomical stages under general anaesthesia, typically lasting two to four hours depending on tumor size and vascularity.
- Nasal corridor creation: The ENT surgeon decongests the nasal mucosa and widens the operative corridor using rigid endoscopes. When needed, a vascularised nasoseptal flap is prepared and stored in the nasopharynx for skull base reconstruction.
- Sphenoidotomy and bone exposure: The anterior wall of the sphenoid sinus is opened. Using micro-drills under continuous intraoperative neuronavigation linked to pre-operative MRI and CT scans, surgeons expose the bony floor of the sella turcica.
- Dural opening and tumor debulking: The dura is opened with micro-instruments. The neurosurgeon debulks the tumor and dissects the capsule away from the pituitary stalk, normal gland tissue, and optic chiasm.
- Multi-layer skull base repair: After tumor removal and haemostasis, any opening into cerebrospinal fluid (CSF) spaces is sealed with autologous tissue, collagen matrix, and the vascularised flap to prevent fluid leaks.
Does transnasal resection of tumor work, and what does clinical evidence show?
Clinical evidence demonstrates that endoscopic transnasal resection achieves gross total removal in 70% to 90% of non-invasive pituitary macroadenomas and midline skull base tumors. Success depends primarily on tumor size, histology, and whether adjacent structures are invaded.
For hormone-secreting adenomas—such as prolactinomas resistant to medication, growth-hormone tumors causing acromegaly, or ACTH-secreting tumors causing Cushing's disease—endoscopic resection achieves hormonal remission in 60% to 80% of microadenomas. When macroadenomas compress the optic chiasm, surgical decompression improves or stabilises vision in over 85% of patients, frequently within days of surgery.
However, tumors extending laterally into the cavernous sinus or encasing the carotid artery cannot always be removed completely without risking nerve damage. In such cases, surgeons perform subtotal decompression followed by targeted stereotactic radiosurgery. A reliable surgical team will not promise complete excision without reviewing high-resolution neuroimaging.
Transnasal resection of tumor cost in Turkey compared with the UK, US and Germany
Transnasal resection of tumor cost reflects the sophisticated infrastructure required: high-definition endoscopes, stereotactic neuronavigation, a dual-surgeon team, neuro-anaesthesia, and intensive care monitoring. Hospital operating costs vary widely across countries, leading to substantial international transnasal resection of tumor price differences.
| Country | Approximate cost range |
|---|---|
| Turkey | €8,500 – €22,000 |
| United Kingdom | €20,000 – €45,000 |
| United States | €45,000 – €110,000 |
| Germany | €18,000 – €40,000 |
Prices vary based on tumor size, need for complex skull base reconstruction, ICU duration, and post-operative hormone testing. International packages in Turkey typically include pre-operative imaging, surgeon and anaesthetist fees, operating theatre supplies, ICU stay, private room recovery, pathology, and airport transfers. You can obtain an itemised assessment by requesting a free quote with your MRI reports.
Endoscopic transnasal resection, open craniotomy or stereotactic radiosurgery?
Choosing between skull base techniques requires balancing tumor clearance against neurological preservation. For an overview of cranial procedures, see our guide to neurosurgery treatments in Turkey.
| Method | Best suited to | Typical limits |
|---|---|---|
| Endoscopic transnasal resection | Midline skull base lesions, pituitary adenomas, craniopharyngiomas, chordomas | Not suited for lateral tumors extending past optic nerves or carotid arteries |
| Open transcranial craniotomy | Extensive suprasellar masses or tumors invading brain parenchyma | Requires scalp incision, bone flap removal, brain retraction, and longer recovery |
| Stereotactic radiosurgery | Small residual margins, recurrences, or patients unfit for open surgery | Does not provide immediate decompression; mass reduction takes months |
Multidisciplinary teams often combine approaches. A large tumor causing optic compression may be debulked transnasally, with residual cavernous sinus fragments managed later with radiosurgery.
Who is a suitable candidate for transnasal tumor surgery?
Candidate suitability is assessed collaboratively by a neurosurgeon, an ENT specialist, an endocrinologist, and an ophthalmologist. Suitable candidates generally include:
- Patients with pituitary macroadenomas (larger than 10 mm) compressing the optic chiasm.
- Individuals with functioning adenomas causing acromegaly, Cushing's disease, or drug-resistant prolactinoma.
- Patients with accessible midline lesions such as tuberculum sellae meningiomas, clival chordomas, or craniopharyngiomas.
- Individuals with progressive visual field loss or persistent cranial headaches.
Patients are less suited if the tumor spreads far laterally into the brain, if active sinonasal bacterial infection is present, or if severe medical conditions preclude general anaesthesia. Asymptomatic, non-functioning microadenomas are usually monitored with periodic MRI scans rather than operated on immediately.
Transnasal resection of tumor before and after: scans, vision and endocrine recovery
When assessing transnasal resection of tumor before and after results, patients should focus on objective clinical measures rather than appearance. Because the operation uses the nostrils, there are no external facial scars and the external profile of the nose is unchanged in standard procedures.
- Neuroimaging scans: Pre-operative MRI scans document tumor dimensions and optic compression. Post-operative scans performed within 48 hours and at three months confirm decompression of the visual pathways and flap integrity.
- Visual field tests: Perimetry testing documents visual recovery, showing reversal of bitemporal hemianopsia once pressure on the optic chiasm is lifted.
- Endocrine panels: Blood assays track hormone normalisation, confirming whether growth hormone, IGF-1, or cortisol levels drop to remission targets.
Patients should rely on radiological and biochemical verification rather than photographic galleries, which do not reflect internal cranial outcomes.
Recovery timeline and your hospital stay in Turkey
Managing transnasal resection of tumor recovery requires careful precautions to protect the healing skull base. When considering transnasal resection of tumor Turkey travel, patients should plan for a 10 to 14-day trip to complete pre-operative assessments, surgery, inpatient recovery, and follow-up clearance before flying. Coordinators assist throughout your visit; learn how it works for international patients.
- Days 1–2 (Intensive Care): Monitored in the neuro-ICU for neurological status, vision, urine output, and fluid balance to check for diabetes insipidus. Nasal packing or dissolvable spacers cause temporary mouth-breathing.
- Days 3–5 (Inpatient Ward): Transferred to a private room and mobilised gently. Patients must strictly avoid nose-blowing, heavy coughing, straining, and drinking through straws to protect the skull base seal.
- Days 6–10 (Hotel Stay & Follow-up): Resting at a local hotel. The ENT surgeon performs endoscopic nasal inspection and gentle debridement. The neurosurgeon reviews follow-up scans and clears travel.
- Weeks 2–8 (Home Recovery): Sedentary work resumes, but heavy lifting (over 5 kg) and flying are avoided for four to six weeks. Saline nasal rinses support internal mucosal healing over six to twelve weeks.
Potential risks and complications of transnasal skull base resection
Transnasal skull base resection is an intricate neurosurgical intervention. According to clinical guidance from the National Health Service (NHS), ENT UK, and the American Association of Neurological Surgeons (AANS), potential complications include:
- Cerebrospinal fluid (CSF) leak: If the dural repair does not seal fully, CSF may leak from the nose. While vascularised flaps have reduced this risk, persistent leaks may require temporary lumbar drainage or endoscopic re-sealing.
- Meningitis: Bacteria entering through a CSF fistula can infect the meninges, requiring intravenous antibiotic treatment.
- Hypopituitarism: Surgical manipulation around the normal gland or stalk can cause hormone deficiencies requiring temporary or lifelong replacement therapy.
- Diabetes insipidus: Posterior pituitary disturbance can cause temporary excessive thirst and urination, managed with desmopressin.
- Vascular and visual injury: Internal carotid artery injury is rare in experienced units but represents a critical emergency. Optic nerve damage can affect vision.
- Nasal symptoms: Nasal crusting, temporary loss of smell (hyposmia), and congestion occur commonly during tissue healing.
How to choose a neurosurgical centre and questions to ask
Selecting a hospital for transnasal skull base surgery requires careful verification of clinical standards. Skull base surgery requires a tertiary hospital with comprehensive neurosurgical facilities. Red flags include receiving quotes without submitting original DICOM MRI scans, lack of an on-site neuro-ICU, surgeons operating without an ENT partner, and representatives minimising potential risks. Before committing, check how it works when arranging surgery abroad, and request a free quote for clinical review.
Essential questions to ask your surgical team include:
- Does your hospital use a co-surgeon team of a board-certified neurosurgeon and an ENT rhinologist?
- How many endoscopic transnasal skull base resections does your department perform each year?
- What intraoperative neuronavigation and endoscopic video equipment do you use?
- Is there an on-site neuro-intensive care unit staffed by dedicated neurointensivists?
- How are post-operative hormone levels and electrolyte balances tracked?
- What specific protocol is followed if a post-operative CSF leak occurs?
- Who handles outpatient nasal debridement and remote follow-up after I return home?
Hospitals with Neurosurgery in Turkey
Frequently asked questions
Transnasal resection of tumor is a minimally invasive neurosurgical technique where surgeons access and remove skull base or pituitary tumors through the nostrils. Using high-definition rigid endoscopes and precision micro-instruments, a joint team of an ENT rhinologist and a skull base neurosurgeon traverses the sphenoid sinus, avoiding any external facial incisions or open cranial surgery.
Yes, clinical evidence confirms it is highly effective for midline skull base tumors such as pituitary adenomas and craniopharyngiomas. Studies show complete tumor clearance in 70% to 90% of non-invasive cases, with rapid relief of optic nerve compression in over 85% of patients. However, tumors invading laterally into the cavernous sinus may require additional stereotactic radiotherapy.
Approximate costs in Turkey typically range from €8,500 to €22,000, compared with €20,000 to €45,000 in the UK and €45,000 to €110,000 in the US. The exact price depends on tumor complexity, duration of intensive care, surgical consumables, and reconstruction materials; hospitals provide written quotes following neuroimaging review.
Post-operative MRI scans typically demonstrate decompression of the optic chiasm, empty sellar space, and positioning of reconstructive tissue flaps where the tumor was removed. Because the surgery enters through the natural nasal cavities, there are no visible external scars or facial changes; recovery is documented through radiological imaging and hormone panels.
Initial hospital recovery takes four to six days, including one or two nights in the intensive care unit. Full recovery generally requires six to twelve weeks. Patients must avoid blowing their nose, heavy lifting, or strenuous activity for at least six weeks to allow the delicate skull base seal to heal.
Most patients report moderate nasal congestion, sinus pressure, and headaches rather than acute surgical pain, because no facial bones or cranial scalp nerves are severed. Discomfort is well controlled with standard prescribed analgesics and typically subsides within the first one to two weeks following surgery.
When a benign pituitary adenoma or skull base tumor is completely excised, the resection is often permanent. However, long-term recurrence rates range between 10% and 20% over ten years for certain lesions. Routine annual MRI scans and endocrine blood tests are essential to monitor for any delayed tumor regrowth.
In specialised skull base centers, endoscopic transnasal surgery has a strong safety record. Recognized complications include cerebrospinal fluid leakage, meningitis, temporary diabetes insipidus, hypopituitarism, and rare vascular injury. Choosing an experienced multidisciplinary team with intraoperative neuronavigation and dedicated neuro-intensive care significantly minimises these surgical risks.
For midline skull base and sellar tumors, transnasal resection is generally preferred because it avoids brain retraction, scalp incisions, and visible scarring, resulting in shorter hospital stays and quicker recovery. However, open craniotomy remains necessary for large tumors extending laterally beyond the reach of the endoscopic nasal corridor.
Patients should plan for a total stay of 10 to 14 days in Turkey. This window accommodates pre-operative neuro-imaging and blood tests, four to six days in hospital, post-discharge nasal endoscopic cleaning, and final specialist clearance before boarding your return flight home.
Patient stories